insights_auto
Why is INO down 16,21%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,22 $
arrow_downward
-16,21%(-0,24) 1D
1,22 $
arrow_upward
+0,40% (+0,0049)bedtimeAfter hours
Closed: 6 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,12 $
High
1,27 $
Low
1,07 $
Mkt. cap
125,63 млн
Avg. vol.
16,17 млн
Volume
36,60 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,12 $
High
1,27 $
Low
1,07 $
Mkt. cap
125,63 млн
Avg. vol.
16,17 млн
Volume
36,60 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
2 сағат бұрын
Jefferies raises Inovio stock price target on regulatory win
Investing.com
·
3 сағат бұрын
Why is Inovio Pharmaceuticals stock plunging today?
BigGo Finance
·
3 сағат бұрын
Inovio Shares Sink 25% After $75 Million Stock Sale Priced at $1.05
Benzinga
·
8 сағат бұрын
12 Health Care Stocks Moving In Friday's Pre-Market Session
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc